Guidelines for the Diagnosis and Treatment of Hidradenitis Suppurativa in the UAE: A Consensus from the Emirates Dermatology Society - Poll - MDSpire

Guidelines for the Diagnosis and Treatment of Hidradenitis Suppurativa in the UAE: A Consensus from the Emirates Dermatology Society

  • By

  • Ahmed Ameen

  • Fatima Albreiki

  • Ayman Alnaeem

  • Muna Al Murrawi

  • Huda R. Ali

  • Raghda Almaashari

  • Fatima AL-Marzooqi

  • Jawaher Alnaqbi

  • Hussein A. Dayem

  • Mohamed Ahmed

  • Waqas Saad

  • Srikumar Goturu

  • Samir Hantirah

  • Ashraf Reda

  • Christos C. Zouboulis

  • February 17, 2026

  • 0 min

Share

Original Source(s)

Guidelines for the Diagnosis and Treatment of Hidradenitis Suppurativa in the UAE: A Consensus from the Emirates Dermatology Society

  • by Ahmed Ameen, Fatima Albreiki, Ayman Alnaeem, Muna Al Murrawi, Huda R. Ali, Raghda Almaashari, Fatima AL-Marzooqi, Jawaher Alnaqbi, Hussein A. Dayem, Mohamed Ahmed, Waqas Saad, Srikumar Goturu, Samir Hantirah, Ashraf Reda, Christos C. Zouboulis

  • February 17, 2026

Related Content

FDA Approves Secukinumab for Adolescents With Moderate to Severe Hidradenitis Suppurativa

Secukinumab becomes the only interleukin-17A inhibitor approved for pediatric patients aged 12 years and older with moderate to severe hidradenitis suppurativa.

Examining TikTok's Influence on Hidradenitis Suppurativa Education Among Individuals with Skin of Color: A Cross-Sectional Study

Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase